Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACOLYTE: Lyumjev vs Lispro in Closed-Loop T1D
NCT05660941Unknown
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of insulin lispro in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Time spent in sensor glucose range (3.9-10.0mmol/l) at 6 hours. Status: unknown.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05660941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05660941.